Search Results - "Borner, Markus M." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Docetaxel, Cisplatin, and Fluorouracil; Docetaxel and Cisplatin; and Epirubicin, Cisplatin, and Fluorouracil As Systemic Treatment for Advanced Gastric Carcinoma: A Randomized Phase II Trial of the Swiss Group for Clinical Cancer Research

Docetaxel, Cisplatin, and Fluorouracil; Docetaxel and Cisplatin; and Epirubicin, Cisplatin, and Fluorouracil As Systemic Treatment for Advanced Gastric Carcinoma: A Randomized Phase II Trial of the Swiss Group for Clinical Cancer Research

by ROTH, Arnaud D, FAZIO, Nicola, WERNLI, Martin, LESLIE, Martin, GLYNNE-JONES, Robert, WIDMER, Lukas, SEYMOUR, Matthew, DE BRAUD, Filippo, STUPP, Roger, FALK, Stephen, BERNHARD, Jürg, SALETTI, Piercarlo, KÖBERLE, Dieter, BORNER, Markus M, RUFIBACH, Kaspar, MAIBACH, Rudolf
Published in Journal of clinical oncology (01.08.2007)

Get full text

Journal Article

Phase II Study of Capecitabine and Oxaliplatin in First- and Second-Line Treatment of Advanced or Metastatic Colorectal Cancer

Phase II Study of Capecitabine and Oxaliplatin in First- and Second-Line Treatment of Advanced or Metastatic Colorectal Cancer

by BORNER, Markus M, DIETRICH, Daniel, MÜLLER, Samuel, BRAUCHLI, Peter, CASTIGLIONE-GERTSCH, Monica, GOLDHIRSCH, Aron, ROTH, Arnaud D, STUPP, Roger, MORANT, Rudolf, HONEGGER, Hanspeter, WERNLI, Martin, HERRMANN, Richard, PESTALOZZI, Bernhard C, SALETTI, Piercarlo, HANSELMANN, Silvia
Published in Journal of clinical oncology (01.04.2002)

Get full text

Journal Article

Oxaliplatin-induced immune pancytopenia

Oxaliplatin-induced immune pancytopenia

by Taleghani, Behrouz Mansouri, Fontana, Stefano, Meyer, Oliver, Ahrens, Norbert, Novak, Urban, Borner, Markus M., Salama, Abdulgabar
Published in Transfusion (Philadelphia, Pa.) (01.05.2005)

Get full text

Journal Article

Alternative Splicing of the Human Cyclin D-binding Myb-like Protein (hDMP1) Yields a Truncated Protein Isoform That Alters Macrophage Differentiation Patterns

Alternative Splicing of the Human Cyclin D-binding Myb-like Protein (hDMP1) Yields a Truncated Protein Isoform That Alters Macrophage Differentiation Patterns

by Tschan, Mario P., Fischer, Kimberlee M., Fung, Vivian S., Pirnia, Farzaneh, Borner, Markus M., Fey, Martin F., Tobler, Andreas, Torbett, Bruce E.
Published in The Journal of biological chemistry (31.10.2003)

Get full text

Journal Article

The medical management of prostate cancer: a multidisciplinary team approach

The medical management of prostate cancer: a multidisciplinary team approach

by STERNBERG, CORA N., KRAINER, MICHAEL, OH, WILLIAM K., BRACARDA, SERGIO, BELLMUNT, JOAQUIM, OZEN, HALUK, ZLOTTA, ALEXANDRE, BEER, TOMASZ M., OUDARD, STEPHANE, RAUCHENWALD, MICHAEL, SKONECZNA, IWONA, BORNER, MARKUS M., FITZPATRICK, JOHN M.
Published in BJU international (01.01.2007)

Get full text

Journal Article

Ex Vivo Assessment of Chemotherapy-induced Apoptosis and Associated Molecular Changes in Patient Tumor Samples

Ex Vivo Assessment of Chemotherapy-induced Apoptosis and Associated Molecular Changes in Patient Tumor Samples

by PIRNIA, Farzaneh, FRESE, Steffen, GLOOR, Beat, HOTZ, Michel A, LUETHI, Alexander, GUGGER, Mathias, BETTICHER, Daniel C, BORNER, Markus M
Published in Anticancer research (01.05.2006)

Get full text

Journal Article

Novel functional profiling approach combining reverse phase protein microarrays and human 3-D ex vivo tissue cultures: Expression of apoptosis-related proteins in human colon cancer

Novel functional profiling approach combining reverse phase protein microarrays and human 3-D ex vivo tissue cultures: Expression of apoptosis-related proteins in human colon cancer

by Pirnia, Farzaneh, Pawlak, Michael, Thallinger, Gerhard G, Gierke, Berthold, Templin, Markus F, Kappeler, Andi, Betticher, Daniel C, Gloor, Beat, Borner, Markus M
Published in Proteomics (Weinheim) (01.07.2009)

Get full text

Journal Article

Apoptosis: its role in the development of malignancies and its potential as a novel therapeutic target

Apoptosis: its role in the development of malignancies and its potential as a novel therapeutic target

by Dixon, S C, Soriano, B J, Lush, R M, Borner, M M, Figg, W D
Published in The Annals of pharmacotherapy (01.01.1997)

Get more information

Journal Article

PG490-mediated sensitization of lung cancer cells to Apo2L TRAIL-induced apoptosis requires activation of ERK2

PG490-mediated sensitization of lung cancer cells to Apo2L TRAIL-induced apoptosis requires activation of ERK2

by FRESE, Steffen, PIRNIA, Farzaneh, MIESCHER, Daniela, KRAJEWSKI, Stan, BORNER, Markus M, REED, John C, SCHMID, Ralph A
Published in Oncogene (21.08.2003)

Get full text

Journal Article

Expression of p16INK4a/p16α and p19ARF/p16β is frequently altered in non-small cell lung cancer and correlates with p53 overexpression

Expression of p16INK4a/p16α and p19ARF/p16β is frequently altered in non-small cell lung cancer and correlates with p53 overexpression

by VONLANTHEN, S, HEIGHWAY, J, BETTICHER, D. C, TSCHAN, M. P, BORNER, M. M, ALTERMATT, H. J, KAPPELER, A, TOBLER, A, FEY, M. F, THATCHER, N, YARBROUGH, W. G
Published in Oncogene (26.11.1998)

Get full text

Journal Article

Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3

Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3

by BORNER, M. M, MYERS, C. E, SARTOR, O, SEI, Y, TOKO, T, TREPEL, J. B, SCHNEIDER, E
Published in Cancer research (Chicago, Ill.) (15.05.1995)

Get full text

Journal Article

Spontaneous Apoptosis and the Expression of p53 and Bcl-2 Family Proteins in Locally Advanced Head and Neck Cancer

Spontaneous Apoptosis and the Expression of p53 and Bcl-2 Family Proteins in Locally Advanced Head and Neck Cancer

by Hotz, Michel A, Bosq, Jacques, Zbaeren, Peter, Reed, John, Schwab, Guy, Krajewski, Stanislaw, Brousset, Pierre, Borner, Markus M
Published in Archives of otolaryngology--head & neck surgery (01.04.1999)

Get full text

Journal Article

Internucleosomal DNA fragmentation in gerbil hippocampus following forebrain ischemia

Internucleosomal DNA fragmentation in gerbil hippocampus following forebrain ischemia

by Sei, Yoshitatsu, Von Lubitz, Dag K.J.E., Basile, Anthony S., Borner, Markus M., Lin, Rick C.-S., Skolnick, Phil, Fossom, Linda H.
Published in Neuroscience letters (25.04.1994)

Get full text

Journal Article

Incidence of hypocalcemia in patients with castration-resistant prostate cancer treated with denosumab: Data from a non-inferiority phase III trial assessing prevention of symptomatic skeletal events (SSE) with denosumab administered every four weeks (q4w) versus every 12 weeks (q12w)—SAKK 96/12 (REDUSE)

Incidence of hypocalcemia in patients with castration-resistant prostate cancer treated with denosumab: Data from a non-inferiority phase III trial assessing prevention of symptomatic skeletal events (SSE) with denosumab administered every four weeks (q4w) versus every 12 weeks (q12w)—SAKK 96/12 (REDUSE)

by Gillessen, Silke, Von Moos, Roger Anton Fredy, Hayoz, Stefanie, Hawle, Hanne, Cathomas, Richard, Rothermundt, Christian Alexander, Anchisi, Sandro, Mueller, Andreas, Wehrhahn, Tobias, Burmeister, Henning, Stoll, Susanna, Llado, Anna, Borner, Markus M., Pedrazzini, Augusto, Huber-Tribolet, Urs Sebastian, Bohanes, Pierre Oliver, Winterhalder, Ralph C., Fuhrer, Andrea Corinne, Schaer, Corinne, Templeton, Arnoud J.
Published in Journal of clinical oncology (01.03.2019)

Get full text

Journal Article

Type of inducing signal regulates transactivation by p53

Type of inducing signal regulates transactivation by p53

by Borner, Markus M, Joncourt, Franziska, Hotz, Michel A
Published in Biochimica et biophysica acta (11.10.1997)

Get full text

Journal Article

Neoadjuvant chemoradiation (CRT) with or without panitumumab (Pan) in patients with K-ras unmutated, locally advanced rectal cancer (LARC): Final results of a randomized multicenter phase II trial (SAKK 41/07)

Neoadjuvant chemoradiation (CRT) with or without panitumumab (Pan) in patients with K-ras unmutated, locally advanced rectal cancer (LARC): Final results of a randomized multicenter phase II trial (SAKK 41/07)

by Helbling, Daniel, Bodoky, Gyorgy, Gautschi, Oliver, Hayoz, Stefanie, Bosman, Fred, Madlung, Axel, Gloor, Beat, Burkhard, Roger, Rauch, Daniel, Winterhalder, Ralph C., Saletti, Piercarlo, Widmer, Lukas, Borner, Markus M., Baertschi, Daniela, Yan, Pu, Koeberle, Dieter
Published in Journal of clinical oncology (20.01.2015)

Get full text

Journal Article

SAKK 24/09: Safety and tolerability of bevacizumab plus paclitaxel versus bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer—A multicenter, randomized phase III trial

SAKK 24/09: Safety and tolerability of bevacizumab plus paclitaxel versus bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer—A multicenter, randomized phase III trial

by Rochlitz, Christoph, von Moos, Roger, Bigler, Martin, Zaman, Khalil, Anchisi, Sandro, Küng, Marc, Baertschi, Daniela, Borner, Markus M., Rordorf, Tamara, Rauch, Daniel, Mueller, Andreas, Ruhstaller, Thomas, Vetter, Marcus, Bernhard, Juerg, Trojan, Andreas, Hasler-Strub, Ursula, Cathomas, Richard, Winterhalder, Ralph C.
Published in Journal of clinical oncology (20.05.2014)

Get full text

Journal Article

A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity

A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity

by Borner, M. M., Bernhard, J., Dietrich, D., Popescu, R., Wernli, M., Saletti, P., Rauch, D., Herrmann, R., Koeberle, D., Honegger, H., Brauchli, P., Lanz, D., Roth, A. D.
Published in Annals of oncology (01.02.2005)

Get full text

Journal Article

Bevacizumab continuation versus no continuation after first-line chemo-bevacizumab therapy in patients with metastatic colorectal cancer: A randomized phase III noninferiority trial (SAKK 41/06)

Bevacizumab continuation versus no continuation after first-line chemo-bevacizumab therapy in patients with metastatic colorectal cancer: A randomized phase III noninferiority trial (SAKK 41/06)

by Koeberle, Dieter, Betticher, Daniel C., Von Moos, Roger, Dietrich, Daniel, Brauchli, Peter, Baertschi, Daniela, Matter-Walstra, Klazien, Winterhalder, Ralph C., Borner, Markus M., Anchisi, Sandro, Moosmann, Peter, Kollar, Attila, Saletti, Piercarlo, Roth, Arnaud, Frueh, Martin, Kueng, Marc, Popescu, Razvan A., Schacher, Sabina, Hess, Viviane, Herrmann, Richard
Published in Journal of clinical oncology (20.05.2013)

Get full text

Journal Article

Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23/82) comparing tamoxifen with observation

Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23/82) comparing tamoxifen with observation

by Waeber, M., Castiglione-Gertsch, M., Dietrich, D., Thürlimann, B., Goldhirsch, A., Brunner, K. W., Borner, M. M.
Published in Annals of oncology (01.08.2003)

Get full text

Journal Article